ADA-friendly PDF: Treatment Guidelines: Tailored Echocardiographic Monitoring in Breast Cancer Patients Receiving HER2-Directed Treatments and/or Anthracyclines

Tailored Echocardiographic Monitoring in Breast Cancer Patients Receiving HER2-Directed Treatments and/or Anthracyclines

Back to Symposium

The Breast Oncology Center at Dana-Farber Brigham Cancer Center held multidisciplinary meetings in 2022 and 2023 to discuss recommendations for tailored echocardiographic monitoring in patients receiving HER2-directed treatments and/or anthracyclines.